These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22978408)

  • 1. The use of a subanesthetic infusion of intravenous ketamine to allow withdrawal of medically prescribed opioids in people with chronic pain, opioid tolerance and hyperalgesia: outcome at 6 months.
    Quinlan J
    Pain Med; 2012 Nov; 13(11):1524-5. PubMed ID: 22978408
    [No Abstract]   [Full Text] [Related]  

  • 2. Opioid-sparing effect of intravenous outpatient ketamine infusions appears short-lived in chronic-pain patients with high opioid requirements.
    Kapural L; Kapural M; Bensitel T; Sessler DI
    Pain Physician; 2010; 13(4):389-94. PubMed ID: 20648208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subanesthetic, Subcutaneous Ketamine Infusion Therapy in the Treatment of Chronic Nonmalignant Pain.
    Zekry O; Gibson SB; Aggarwal A
    J Pain Palliat Care Pharmacother; 2016 Jun; 30(2):91-8. PubMed ID: 27092576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5-year retrospective analysis.
    Patil S; Anitescu M
    Pain Med; 2012 Feb; 13(2):263-9. PubMed ID: 21939497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High opioid dosage rapid detoxification of cancer patient in palliative care with the Raffaeli model.
    Monterubbianesi MC; Capuccini J; Ferioli I; Tassinari D; Sarti D; Raffaeli W
    J Opioid Manag; 2012; 8(5):292-8. PubMed ID: 23247906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome.
    Correll GE; Maleki J; Gracely EJ; Muir JJ; Harbut RE
    Pain Med; 2004 Sep; 5(3):263-75. PubMed ID: 15367304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol for a randomised, double-blinded, placebo-controlled, clinical trial of S-ketamine for pain treatment in patients with chronic pancreatitis (RESET trial).
    Juel J; Olesen SS; Olesen AE; Poulsen JL; Dahan A; Wilder-Smith O; Madzak A; Frøkjær JB; Drewes AM
    BMJ Open; 2015 Mar; 5(3):e007087. PubMed ID: 25757947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term use of an intravenous ketamine infusion in a child with significant burns.
    White MC; Karsli C
    Paediatr Anaesth; 2007 Nov; 17(11):1102-4. PubMed ID: 17897278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine for acute-on-chronic pain.
    Vaid P
    Can Nurse; 2013 Oct; 109(8):20-1. PubMed ID: 24283148
    [No Abstract]   [Full Text] [Related]  

  • 10. Propofol alters ketamine effect on opiate-induced hyperalgesia.
    Ben-David B; Chelly JE
    Anesth Analg; 2009 Apr; 108(4):1353; author reply 1353-4. PubMed ID: 19299816
    [No Abstract]   [Full Text] [Related]  

  • 11. Ultra-low dose ketamine and memantine treatment for pain in an opioid-tolerant oncology patient.
    Grande LA; O'Donnell BR; Fitzgibbon DR; Terman GW
    Anesth Analg; 2008 Oct; 107(4):1380-3. PubMed ID: 18806055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies with ketamine and alfentanil following Freund's complete adjuvant-induced inflammation in rats.
    Edwards SR; Mather LE; Smith MT
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):414-20. PubMed ID: 17439409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subanesthetic ketamine infusions for the treatment of children and adolescents with chronic pain: a longitudinal study.
    Sheehy KA; Muller EA; Lippold C; Nouraie M; Finkel JC; Quezado ZM
    BMC Pediatr; 2015 Dec; 15():198. PubMed ID: 26620833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose intravenous ketamine and clonidine for poor postoperative opioid responsiveness: a double blind randomized study.
    Salengros JC; Hecquet F; Touihri K; Sekkat J; Barvais L; Engelman E
    Acta Anaesthesiol Belg; 2011; 62(2):65-72. PubMed ID: 21919372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
    Dunbar SA; Karamian I; Zhang J
    Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The early and delayed analgesic effects of ketamine after total hip arthroplasty: a prospective, randomized, controlled, double-blind study.
    Remérand F; Le Tendre C; Baud A; Couvret C; Pourrat X; Favard L; Laffon M; Fusciardi J
    Anesth Analg; 2009 Dec; 109(6):1963-71. PubMed ID: 19923527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Addition of ketamine infusion to patient controlled analgesia with intravenous morphine after abdominal hysterectomy].
    Pirim A; Karaman S; Uyar M; Certuğ A
    Agri; 2006 Jan; 18(1):52-8. PubMed ID: 16783669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalized hyperalgesia and allodynia following abrupt cessation of subcutaneous ketamine infusion.
    Mitchell AC
    Palliat Med; 1999 Sep; 13(5):427-8. PubMed ID: 10659115
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjunct continuous intravenous ketamine infusion for postoperative pain relief following posterior spinal instrumentation for correction of scoliosis: a case report.
    Tsui BC; Wagner A; Mahood J; Moreau M
    Paediatr Anaesth; 2007 Apr; 17(4):383-6. PubMed ID: 17359410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful reversal of hyperalgesia/myoclonus complex with low-dose ketamine infusion.
    Forero M; Chan PS; Restrepo-Garces CE
    Pain Pract; 2012 Feb; 12(2):154-8. PubMed ID: 21676160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.